Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

30.98 +0.33 (+1.08%)
Streaming Delayed Price Updated: 11:59 AM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 383,112
Open 30.49
Bid (Size) 30.95 (1)
Ask (Size) 31.01 (2)
Prev. Close 30.65
Today's Range 29.82 - 31.28
52wk Range 22.66 - 51.94
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
These stocks may take off in a market favoring growth. 
Via The Motley Fool
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates... 
Via Benzinga

Performance

YTD
-10.59%
-10.59%
1 Month
+30.00%
+30.00%
3 Month
-18.50%
-18.50%
6 Month
-32.02%
-32.02%
1 Year
-35.81%
-35.81%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Ratings for Intellia Therapeutics
Via Benzinga
2 Brilliant Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Down 45%, Is Intellia a Buy?
Via The Motley Fool
Why Intellia Therapeutics Stock Is Surging Tuesday
Via Benzinga
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
Via Benzinga
3 Biotech Stocks That Are Betting on the Future of Gene Editing
Via InvestorPlace
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
Via Investor's Business Daily
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years
Via The Motley Fool
Intellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy?
Via The Motley Fool
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too
Via The Motley Fool
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Richer Over Time
Via The Motley Fool
Cathie Wood's Ark Offloads $6.3M In Tesla Shares Amid EV Maker's Q3 Earnings Disappointment
Via Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
Via InvestorPlace
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Via Investor's Business Daily
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
Via The Motley Fool
2 Growth Stocks That Could Deliver Parabolic Returns in Under 5 Years
Via The Motley Fool
Cathie Wood's Ark Invest Sells $9.8M Worth Of Tesla Shares — Second Day Of Selling EV Giant In A Row
Via Benzinga
Cathie Wood's Ark Invest Keeps On Cutting Tesla Holdings, Sells More Than $8M Worth Of EV Maker's Shares
Via Benzinga
This Cathie Wood Stock Is Poised to Double, Says Wall Street
Via The Motley Fool
Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy?
Via The Motley Fool
Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Are Gene Therapy Stocks The Market's Next Big Winners?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.